Einsatz von Protonenpumpenhemmern bei Patienten mit Leberzirrhose – eine Umfrage unter Hepatologen in Deutschland
暂无分享,去创建一个
J. Trebicka | A. Lohse | C. Steib | J. Kluwe | T. Horvatits | A. Drolz | M. Wehmeyer
[1] G. Guyatt,et al. Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients. , 2018, The New England journal of medicine.
[2] P. Hylemon,et al. Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis , 2018, The American Journal of Gastroenterology.
[3] P. Hayes,et al. The impact of proton pump inhibitor therapy on patients with liver disease , 2016, Alimentary pharmacology & therapeutics.
[4] H. Vilstrup,et al. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites , 2016, Hepatology.
[5] Josef Coresh,et al. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease. , 2016, JAMA internal medicine.
[6] U. Rosien,et al. [S2k guideline: quality requirements for gastrointestinal endoscopy, AWMF registry no. 021-022]. , 2016, Zeitschrift fur Gastroenterologie.
[7] J. Lam,et al. Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis , 2015, PloS one.
[8] K. Reddy,et al. Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[9] B. Kronenberger,et al. Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis , 2015, Alimentary pharmacology & therapeutics.
[10] D. Johnson,et al. Reported side effects and complications of long-term proton pump inhibitor use: dissecting the evidence. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[11] Adrian V. Hernández,et al. Acid‐suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: A meta‐analysis , 2013, Journal of gastroenterology and hepatology.
[12] N. Chavez-Tapia,et al. PPIs are not associated with a lower incidence of portal-hypertension-related bleeding in cirrhosis. , 2010, World journal of gastroenterology.
[13] G. Garcia‐Tsao,et al. Management of gastropathy and gastric vascular ectasia in portal hypertension. , 2010, Clinics in liver disease.
[14] R. Hoffmann,et al. Association of Proton Pump Inhibitor Therapy With Spontaneous Bacterial Peritonitis in Cirrhotic Patients With Ascites , 2009, The American Journal of Gastroenterology.
[15] B. Stricker,et al. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. , 2004, JAMA.
[16] T. Su,et al. Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study. , 2017, Gastroenterology.